Multimodal Imaging Market size was valued at USD 3.42 billion in 2024 and is set to exceed USD 7.57 billion by 2037, registering over 6.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of multimodal imaging is evaluated at USD 3.59 billion.
The market is estimated to grow on the back of the rising level of the geriatric population globally as they are more prone to chronic diseases and the increasing research & development in radiotracer technology along with government support for promoting multimodal imaging research through research grants. According to the World Health Organization data, the global population of people aged 60 and above is expected to increase to 1.4 billion by the end of 2030 and this figure is projected to reach 2.1 billion by 2050.
Multimodal imaging technology helps in the early detection of diseases in fields such as urology and oncology. The global multimodal imaging market is estimated to witness growth on account of its increasing adoption in various applications including urology, cardiology, and neurological surgeries. Moreover, increasing technological advancements in diagnostic imaging modalities are also expected to drive the growth of the global multimodal imaging market in the coming years. Furthermore, the rapid development of software that provides accurate data and interpretation is anticipated to increase the usage of multimodal imaging for diagnosis, identification of diseases, improve treatment processes, and enhance patient monitoring. Moreover, multimodal imaging has been highly used by surgeons owing to the recent technological advancements and increased preference for minimally invasive medical procedures along with the early need treatment intervention. In addition, the usage of different types of multimodal imaging techniques such as PET/CT, MR/CT, SPECT/CT, and CT/CT is anticipated to generate revenue for the market as multimodal imaging helps locate disease and anatomically guide the surgeon and aid patients to receive better treatment.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
6.3% |
Base Year Market Size (2024) |
USD 3.42 billion |
Forecast Year Market Size (2037) |
USD 7.57 billion |
Regional Scope |
|
End-user (Hospitals, Diagnostic Imaging Centers)
The global multimodal imaging market is segmented and analyzed for demand and supply by end-user in hospitals, diagnostic imaging centers, and others. Out of these segments, the hospital segment is anticipated to garner the largest market share by the end of 2037, backed by the rising number of hospitals globally along with the increasing growth of the hospital industry. According to the data, the total number of hospitals in the United States in 2020 was about 6,000 and the number of hospitals in Japan in the same year was about 8,100. Furthermore, multimodal imaging is mostly present in hospital settings by medical professionals which makes it the first choice for patients suffering from diseases for proper treatment. Also, the development of multimodal imaging devices in hospitals along with the presence of various imaging technologies including hyperpolarized MRS, PET, and molecular ultrasound imaging is expected to support revenue growth of this segment.
Application (Brain & Neurology, Cardiology, Oncology, Ophthalmology)
The global multimodal imaging market is also segmented and analyzed for demand and supply by application into brain & neurology, cardiology, oncology, ophthalmology, and others. Out of these, the cardiology segment is attributed to holding a significant share during the assessment period. Various features of multimodal imaging which include echocardiography, cardiac computed tomography (CCT), cardiac magnetic resonance (CMR), and nuclear cardiology have helped doctors to understand and perform the treatment of cardiovascular disease. This trend is anticipated to contribute positively to segment growth. Multimodal imaging has also helped in performing noninvasive procedures on patients suffering from coronary artery disease, structural heart disease, arrhythmia, and heart failure. Multimodal imaging techniques have efficiently assisted patients in cardiovascular diagnostics. This factor is projected to drive segment growth to a significant extent.
Our in-depth analysis of the global market includes the following segments:
By Product |
|
By Technology |
|
By Application |
|
By End User |
|
The North America multimodal imaging market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. This can be accredited to the rising prevalence of cardiovascular diseases, the adoption of multimodal imaging systems in cardiology, and increasing healthcare expenditure in the region. According to statistics, about 695,000 patients die from heart disease every year in the United States. In addition, approximately 804,000 US citizens suffer a heart attack each year. Also, the presence of a strong healthcare network in the region, the availability of major market players along with their innovative product launches, massive investments for the development of advanced imaging systems, and growing adoption of technologically developed medical imaging and visualization systems are anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of imaging products are also anticipated to boost market growth during the forecast period.
United Imaging Healthcare Co., Ltd. - introduced uEXPLORER, a total-body PET/CT technology system.
General Electric Company’s - subsidiary GE Healthcare, launched its 800 series SPECT/CT systems including the NM 830, NM/CT 850, NM/CT 860, NM/CT 860 DR, NM/CT 870 CZT, and a nuclear medicine workstation.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?